Can CRISPR Gene Editing Cure Muscular Dystrophy?
Source: Bio-Rad
By Dr. Chengzu Long -New York University School of Medicine
Genetic editing seems to be the hottest science topic these days. But, how are researchers actually using editing tools? This month, we talk with Dr. Chengzu Long from the New York University School of Medicine and discuss his use of CRISPR to correct Duchenne muscular dystrophy. Plus, we learn about how his team successfully corrected a genetic mutation in a 3-D heart tissue model and restored the heartbeat to levels close to that seen in the wild type model.
access the Podcast!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.
Subscribe to Drug Discovery Online
X
Subscribe to Drug Discovery Online
Bio-Rad
This website uses cookies to ensure you get the best experience on our website. Learn more